Life Sciences

DiAthegen

Early-stage biopharmaceutical developer of therapeutic & diagnostic products based on gene and protein technologies. Learn more at www.diathegen.com

LigoCyte Pharmaceuticals

Specialty pharmaceutical vaccine developer of a new generation of vaccines and monoclonal antibody therapeutics for the prevention and treatment of infectious diseases and inflammation. Learn more at www.ligocyte.com

Akebia Therapeutics

Late-preclinical stage biopharmaceutical drug developer for anemia and peripheral vascular disease indications. Learn more at www.akebia.com

Windy Hill Medical, Inc.

Specialty pharmaceuticals oncology developer of a novel approach to breast cancer therapy, adding new therapeutic options for women at risk.

Archemix Corp.

Biotech developer of proprietary platform of aptamer therapeutics. Learn more at www.archemix.com

Verus Pharmaceuticals

Branded specialty pharmaceuticals company with a pediatric orientation. Learn more at www.veruspharm.com

Micromet, Inc.

(NASDAQ: MITI)

Biopharmaceutical developer of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Learn more at www.micromet.de

Pain Therapeutics, Inc.

(NASDAQ: PITE)

Biopharmaceutical developer of novel drugs for pain management and hematology/oncology. Learn more at www.paintrials.com